Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Herpes simplex infection (mmu05168)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
14927508
3
KLA  ATP  ATP+KLA
 149275083 Unknown KLA .74 .68 .68 .77 .71 .85 .69
ATP .85 .69 1.26 .89 .89 1.26 .64
KLA/ATP .64 .63 1.07 .96 1.39 1.07 .82
Arntl
KLA  ATP  ATP+KLA
 NM_007489 aryl hydrocarbon receptor nuclear translocator-like (Arntl), mRNA [NM_007489] KLA .70 .70 .80 .60 .68 .79 .67
ATP 1.10 1.00 .65 .56 1.53 1.42 1.48
KLA/ATP .71 .60 .47 .42 1.07 1.02 1.27
BB229853
KLA  ATP  ATP+KLA
 BB229853 gb|BB229853 RIKEN full-length enriched, 3 days neonate thymus Mus musculus cDNA clone A630023O21 3. [BB229853] KLA 6.32 5.94 6.13 6.41 7.39 12.33 6.08
ATP .39 .24 .33 .38 1.18 5.75 2.85
KLA/ATP 2.27 2.02 3.25 4.04 7.11 10.22 13.93
C1qbp
KLA  ATP  ATP+KLA
 NM_007573 complement component 1, q subcomponent binding protein (C1qbp), nuclear gene encoding mitochondrial protein, mRNA [NM_007573] KLA .77 .75 .65 .58 .41 .29 .49
ATP .92 .94 1.18 1.16 .89 .43 .44
KLA/ATP .71 .70 .79 .78 .60 .25 .12
C3
KLA  ATP  ATP+KLA
 NM_009778 complement component 3 (C3), mRNA [NM_009778] KLA 28.58 25.57 24.39 27.34 23.38 23.21 18.10
ATP 1.04 .93 1.21 1.90 2.80 5.74 12.19
KLA/ATP 27.04 26.10 33.29 23.09 25.65 23.77 40.22
Casp3
KLA  ATP  ATP+KLA
 NM_009810 caspase 3 (Casp3), mRNA [NM_009810] KLA 1.66 1.94 2.47 2.61 3.01 2.96 1.44
ATP .90 .99 1.17 1.30 1.01 1.17 .86
KLA/ATP 1.55 1.87 2.40 2.35 2.27 2.84 2.52
Casp3
KLA  ATP  ATP+KLA
 U49929 ICE-like cysteine protease (Lice) mRNA, complete cds. [U49929] KLA 1.71 1.87 2.69 3.11 3.64 3.42 1.52
ATP 1.04 1.07 1.16 1.34 .98 1.27 .86
KLA/ATP 1.80 1.96 2.46 2.91 2.50 3.24 3.10
Casp8
KLA  ATP  ATP+KLA
 NM_009812 caspase 8 (Casp8), transcript variant 1, mRNA [NM_009812] KLA 2.41 2.53 3.20 3.26 2.75 2.78 1.57
ATP .91 .96 .66 .67 .54 1.53 1.52
KLA/ATP 2.47 2.52 2.08 2.41 1.41 2.50 2.77
Ccl12
KLA  ATP  ATP+KLA
 NM_011331 chemokine (C-C motif) ligand 12 (Ccl12), mRNA [NM_011331] KLA 40.77 33.71 46.23 51.22 57.13 57.92 16.26
ATP 1.41 1.14 1.54 1.79 1.41 1.89 9.34
KLA/ATP 39.52 43.18 61.96 69.72 62.95 38.70 29.25
Ccl2
KLA  ATP  ATP+KLA
 NM_011333 chemokine (C-C motif) ligand 2 (Ccl2), mRNA [NM_011333] KLA 10.26 9.30 8.35 10.02 8.92 14.08 11.59
ATP 1.62 1.68 2.20 4.16 3.92 4.84 17.45
KLA/ATP 10.09 10.31 10.95 12.32 8.00 10.04 21.29
Ccl5
KLA  ATP  ATP+KLA
 M77747 rantes mRNA, complete cds. [M77747] KLA 63.18 60.41 56.25 63.63 58.00 66.51 67.20
ATP .91 1.08 1.25 1.90 4.34 16.10 26.07
KLA/ATP 55.92 63.34 72.91 65.68 70.81 71.97 81.34
Ccl5
KLA  ATP  ATP+KLA
 NM_013653 chemokine (C-C motif) ligand 5 (Ccl5), mRNA [NM_013653] KLA 40.31 35.22 27.92 38.59 29.29 37.98 28.83
ATP .86 .92 1.43 1.66 3.86 15.09 16.66
KLA/ATP 32.14 31.72 47.19 35.89 42.00 46.15 43.89
Cd74
KLA  ATP  ATP+KLA
 NM_001042605 CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) (Cd74), transcript variant 1, mRNA [NM_001042605] KLA 1.55 1.72 1.80 1.45 1.77 1.60 2.05
ATP 1.24 1.54 1.11 2.35 1.58 1.16 2.23
KLA/ATP 2.13 2.19 1.12 3.06 1.61 1.61 4.15
Cdc2a
KLA  ATP  ATP+KLA
 NM_007659 cell division cycle 2 homolog A (S. pombe) (Cdc2a), mRNA [NM_007659] KLA .72 .68 .65 .58 .58 .59 .48
ATP 1.01 1.05 1.21 1.06 .83 .77 .51
KLA/ATP .68 .63 .79 .70 .59 .59 .51
Cdc34
KLA  ATP  ATP+KLA
 AK136078 in vitro fertilized eggs cDNA, RIKEN full-length enriched library, clone:7420453J03 product:Similar to cell division cycle 34 homolog [Mus musculus], full insert sequence. [AK136078] KLA 1.11 1.15 1.14 1.23 1.24 1.41 1.56
ATP .94 .99 1.03 1.18 1.56 2.11 1.79
KLA/ATP 1.13 1.15 1.29 1.31 1.64 1.96 2.18
Cdc34
KLA  ATP  ATP+KLA
 NM_177613 cell division cycle 34 homolog (S. cerevisiae) (Cdc34), mRNA [NM_177613] KLA 1.14 1.13 1.15 1.15 1.18 1.42 1.52
ATP .93 .97 1.04 1.19 1.49 2.17 1.83
KLA/ATP 1.11 1.12 1.24 1.36 1.56 2.01 2.18
Cdk2
KLA  ATP  ATP+KLA
 NM_016756 cyclin-dependent kinase 2 (Cdk2), transcript variant 2, mRNA [NM_016756] KLA .68 .67 .62 .63 .60 .74 .73
ATP 1.02 1.14 .91 .92 .68 .71 .65
KLA/ATP .67 .64 .64 .64 .61 .74 .62
Cfp
KLA  ATP  ATP+KLA
 NM_008823 complement factor properdin (Cfp), mRNA [NM_008823] KLA .89 .88 .92 .86 1.08 1.12 1.29
ATP 1.01 1.06 .83 .92 .73 .65 .97
KLA/ATP .92 .87 .67 .78 .56 .63 .99
Chuk
KLA  ATP  ATP+KLA
 NM_007700 conserved helix-loop-helix ubiquitous kinase (Chuk), mRNA [NM_007700] KLA 1.32 1.42 1.41 1.17 1.32 1.22 1.40
ATP 1.22 1.30 1.18 .97 1.02 1.00 1.37
KLA/ATP 1.56 1.61 1.21 1.09 .83 .84 1.17
Clock
KLA  ATP  ATP+KLA
 AK030352 adult male pituitary gland cDNA, RIKEN full-length enriched library, clone:5330400M04 product:circadian locomoter output cycles kaput, full insert sequence. [AK030352] KLA .79 .74 .74 .76 .93 .88 .95
ATP 1.14 1.22 .70 .72 .98 .89 1.00
KLA/ATP .83 .80 .68 .69 .88 .81 .77
Clock
KLA  ATP  ATP+KLA
 NM_007715 circadian locomoter output cycles kaput (Clock), mRNA [NM_007715] KLA 1.18 1.05 .90 .82 .81 .85 .92
ATP 1.05 1.03 .95 .70 1.12 1.26 .96
KLA/ATP 1.13 1.05 .89 .77 1.00 .95 .93
Crebbp
KLA  ATP  ATP+KLA
 AK048818 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230072N21 product:hypothetical protein, full insert sequence [AK048818] KLA 1.44 1.19 1.26 1.25 1.25 1.36 1.24
ATP .98 .90 1.04 1.11 1.95 2.72 1.51
KLA/ATP 1.17 1.27 1.45 1.28 1.98 2.80 2.52
Crebbp
KLA  ATP  ATP+KLA
 NM_001025432 CREB binding protein (Crebbp), mRNA [NM_001025432] KLA .97 1.01 .98 1.06 1.05 .99 1.07
ATP 1.07 1.05 .96 1.01 1.15 1.14 1.00
KLA/ATP 1.01 .97 .97 1.00 1.03 1.23 1.13
Crebbp
KLA  ATP  ATP+KLA
 S66385 gb|CREB-binding protein [mice, brain, mRNA Partial, 7326 nt]. [S66385] KLA 1.00 .98 1.08 .98 1.04 1.07 1.08
ATP .99 .98 .99 1.09 1.13 1.08 1.05
KLA/ATP 1.06 1.00 1.05 1.03 1.02 1.14 1.11
Csnk2a1
KLA  ATP  ATP+KLA
 NM_007788 casein kinase 2, alpha 1 polypeptide (Csnk2a1), mRNA [NM_007788] KLA 1.36 1.39 1.19 1.34 1.32 1.74 1.86
ATP .92 .88 1.13 .86 1.12 2.50 1.99
KLA/ATP 1.19 1.24 1.35 1.03 1.16 2.09 2.88
Csnk2a2
KLA  ATP  ATP+KLA
 NM_009974 casein kinase 2, alpha prime polypeptide (Csnk2a2), mRNA [NM_009974] KLA 1.46 1.53 1.70 1.47 1.32 1.32 1.17
ATP 1.00 1.11 1.17 1.33 1.71 2.03 1.06
KLA/ATP 1.58 1.67 1.69 2.00 2.20 2.44 1.68
Csnk2b
KLA  ATP  ATP+KLA
 NM_009975 casein kinase 2, beta polypeptide (Csnk2b), mRNA [NM_009975] KLA 1.19 1.10 1.12 1.13 1.20 1.28 1.25
ATP 1.12 1.03 1.04 1.07 1.20 1.27 1.09
KLA/ATP 1.15 1.20 1.25 1.13 1.44 1.34 1.35
Cul1
KLA  ATP  ATP+KLA
 NM_012042 cullin 1 (Cul1), mRNA [NM_012042] KLA 1.54 1.57 1.59 1.36 1.13 1.06 1.15
ATP 1.02 1.15 1.00 1.02 1.00 1.16 1.10
KLA/ATP 1.54 1.68 1.30 1.46 .98 1.02 1.12
Cycs
KLA  ATP  ATP+KLA
 NM_007808 cytochrome c, somatic (Cycs), nuclear gene encoding mitochondrial protein, mRNA [NM_007808] KLA 2.20 2.21 2.35 2.69 2.62 3.22 2.14
ATP .87 .89 1.31 1.05 1.06 1.20 1.26
KLA/ATP 1.88 2.04 2.86 2.26 2.57 2.45 2.03
Cyct
KLA  ATP  ATP+KLA
 NM_009989 cytochrome c, testis (Cyct), mRNA [NM_009989] KLA .93 1.01 1.00 .99 1.02 1.03 .96
ATP 1.01 .91 1.01 .99 .98 .95 .95
KLA/ATP 1.10 .96 .89 .89 1.10 1.05 .97
D430028G
21Rik
KLA  ATP  ATP+KLA
 NM_144888 RIKEN cDNA D430028G21 gene (D430028G21Rik), mRNA [NM_144888] KLA .56 .54 .61 .60 .74 1.03 1.06
ATP 1.07 .99 .69 .66 .48 .96 1.38
KLA/ATP .61 .60 .38 .41 .42 1.00 1.40
Daxx
KLA  ATP  ATP+KLA
 NM_007829 Fas death domain-associated protein (Daxx), mRNA [NM_007829] KLA 13.43 12.31 10.74 10.71 8.02 8.78 4.52
ATP .88 .79 .74 .47 1.05 5.31 2.46
KLA/ATP 11.40 11.89 13.01 10.51 12.32 11.59 9.74
Ddx58
KLA  ATP  ATP+KLA
 NM_172689 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 (Ddx58), mRNA [NM_172689] KLA 8.80 9.12 9.70 9.96 9.92 7.85 5.67
ATP 1.06 .89 .97 .89 .80 3.03 3.67
KLA/ATP 9.18 9.23 10.31 9.25 7.29 6.93 8.99
Eef1d
KLA  ATP  ATP+KLA
 NM_029663 eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) (Eef1d), transcript variant 1, mRNA [NM_029663] KLA .94 .96 .87 .89 .77 .70 .78
ATP .98 1.03 1.07 1.18 1.07 .87 .75
KLA/ATP .99 .97 .95 .92 .93 .74 .52
Eif2ak1
KLA  ATP  ATP+KLA
 AK032508 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430574E03 product:EUKARYOTIC TRANSLATION INITIATION FACTOR 2 ALPHA KINASE 1 (EC 2.7.1.-) (HEME-REGULATED EUKARYOTIC INITIATION FACTOR EIF-2-ALPHA KINASE) (HEME-R KLA .65 .66 .65 .67 .67 .85 1.06
ATP 1.07 1.13 1.10 1.03 .70 .63 .72
KLA/ATP .68 .73 .70 .67 .65 .66 .47
Eif2ak1
KLA  ATP  ATP+KLA
 NM_013557 eukaryotic translation initiation factor 2 alpha kinase 1 (Eif2ak1), mRNA [NM_013557] KLA 1.16 1.19 1.32 1.21 1.58 1.51 1.59
ATP 1.19 1.27 .93 1.28 1.02 1.53 1.60
KLA/ATP 1.36 1.50 1.16 1.38 1.12 1.79 2.42
Eif2ak2
KLA  ATP  ATP+KLA
 NM_011163 eukaryotic translation initiation factor 2-alpha kinase 2 (Eif2ak2), mRNA [NM_011163] KLA 6.20 6.38 6.31 6.36 4.86 4.86 2.93
ATP 1.03 .78 .68 .37 .49 3.38 1.97
KLA/ATP 6.50 5.52 5.25 2.87 3.90 4.33 3.35
Eif2ak3
KLA  ATP  ATP+KLA
 AK041698 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630030N06 product:unclassifiable, full insert sequence. [AK041698] KLA .79 .77 .83 .80 .93 .87 .85
ATP .82 .82 .82 .92 .88 .85 .91
KLA/ATP .77 .76 .78 .80 .84 .86 .81
Eif2ak3
KLA  ATP  ATP+KLA
 NM_010121 eukaryotic translation initiation factor 2 alpha kinase 3 (Eif2ak3), mRNA [NM_010121] KLA .28 .28 .27 .29 .38 .36 .47
ATP 1.17 1.04 .62 .48 .54 .48 .67
KLA/ATP .29 .30 .26 .26 .34 .37 .32
Eif2ak4
KLA  ATP  ATP+KLA
 AF193344 GCN2gamma mRNA, complete cds [AF193344] KLA .78 .78 .66 .72 .79 .83 1.05
ATP .97 1.06 .97 .97 .98 .86 .94
KLA/ATP .81 .73 .62 .84 .81 .88 .90
Eif2ak4
KLA  ATP  ATP+KLA
 NM_013719 eukaryotic translation initiation factor 2 alpha kinase 4 (Eif2ak4), mRNA [NM_013719] KLA .60 .55 .49 .54 .59 .67 .91
ATP 1.11 1.18 1.00 .94 1.33 .90 .98
KLA/ATP .59 .54 .56 .58 .90 .86 .86
Eif2s1
KLA  ATP  ATP+KLA
 NM_026114 eukaryotic translation initiation factor 2, subunit 1 alpha (Eif2s1), mRNA [NM_026114] KLA 1.50 1.49 1.52 1.49 1.24 1.12 1.25
ATP 1.00 .98 1.16 1.05 1.03 1.10 .99
KLA/ATP 1.50 1.54 1.73 1.39 1.24 .87 .66
Ep300
KLA  ATP  ATP+KLA
 AK042627 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730011L11 product:P300 TRANSCRIPTION COACTIVATOR (FRAGMENT) homolog [Mus sp], full insert sequence. [AK042627] KLA 1.02 .95 .92 1.04 1.01 1.00 1.05
ATP 1.06 .89 .88 .89 1.00 .90 1.07
KLA/ATP 1.10 1.02 .87 .91 1.04 .97 .98
Ep300
KLA  ATP  ATP+KLA
 NM_177821 E1A binding protein p300 (Ep300), mRNA [NM_177821] KLA 1.61 1.26 1.57 1.38 1.78 1.41 1.40
ATP 1.34 1.60 1.11 1.08 1.16 1.05 1.15
KLA/ATP 1.86 1.94 1.18 1.56 1.71 1.42 2.05
Fadd
KLA  ATP  ATP+KLA
 NM_010175 Fas (TNFRSF6)-associated via death domain (Fadd), mRNA [NM_010175] KLA .54 .54 .59 .64 .80 .97 1.16
ATP 1.05 1.09 1.03 1.65 1.18 .78 1.61
KLA/ATP .56 .56 .53 .78 .78 .82 1.34
Fas
KLA  ATP  ATP+KLA
 AK086933 0 day neonate lung cDNA, RIKEN full-length enriched library, clone:E030012O08 product:tumor necrosis factor receptor superfamily, member 6, full insert sequence. [AK086933] KLA 6.31 6.56 6.33 6.70 4.93 3.74 2.48
ATP .95 1.04 1.33 1.55 1.85 6.00 2.77
KLA/ATP 5.67 7.16 7.71 7.73 6.02 5.79 7.85
Fas
KLA  ATP  ATP+KLA
 NM_007987 Fas (TNF receptor superfamily member 6) (Fas), mRNA [NM_007987] KLA 17.08 17.45 19.08 17.38 13.33 6.78 4.46
ATP .98 .96 1.64 3.05 5.58 12.91 1.89
KLA/ATP 16.57 17.25 26.06 23.57 22.03 16.74 13.29
Fasl
KLA  ATP  ATP+KLA
 NM_010177 Fas ligand (TNF superfamily, member 6) (Fasl), mRNA [NM_010177] KLA 1.03 1.01 1.03 1.02 1.01 1.01 1.00
ATP 1.00 .99 1.04 1.21 1.18 1.20 1.01
KLA/ATP 1.00 1.02 1.07 1.16 1.18 1.23 1.00
Fos
KLA  ATP  ATP+KLA
 NM_010234 FBJ osteosarcoma oncogene (Fos), mRNA [NM_010234] KLA .42 .33 .64 .61 .71 .85 .71
ATP 3.48 5.46 23.78 25.22 1.71 2.36 1.50
KLA/ATP .90 1.74 5.97 8.62 1.28 2.42 4.52
Gltscr2
KLA  ATP  ATP+KLA
 NM_133831 glioma tumor suppressor candidate region gene 2 (Gltscr2), mRNA [NM_133831] KLA 1.31 1.31 1.30 1.41 1.28 1.09 .93
ATP .98 1.00 1.00 1.31 1.29 1.24 .77
KLA/ATP 1.29 1.42 1.53 1.62 1.60 1.48 .86
Gtf2i
KLA  ATP  ATP+KLA
 AF017085 BAP-135 homolog (Diws1t) mRNA, complete cds. [AF017085] KLA .37 .32 .27 .21 .20 .34 .57
ATP 1.01 .79 .44 .37 .26 .14 .48
KLA/ATP .41 .29 .15 .14 .14 .13 .20
Gtf2i
KLA  ATP  ATP+KLA
 AK085902 16 days neonate heart cDNA, RIKEN full-length enriched library, clone:D830026O16 product:general transcription factor II I, full insert sequence. [AK085902] KLA .94 .89 .89 .85 .91 .90 .89
ATP 1.04 .85 .88 .87 .88 1.00 .94
KLA/ATP .95 .93 .82 .83 .84 .88 .76
Gtf2i
KLA  ATP  ATP+KLA
 NM_010365 general transcription factor II I (Gtf2i), transcript variant 2, mRNA [NM_010365] KLA .41 .39 .32 .25 .26 .42 .62
ATP .89 .72 .46 .41 .29 .20 .61
KLA/ATP .41 .33 .21 .23 .21 .19 .32
Gtf2ird1
KLA  ATP  ATP+KLA
 NM_020331 general transcription factor II I repeat domain-containing 1 (Gtf2ird1), transcript variant 1, mRNA [NM_020331] KLA .42 .39 .33 .39 .40 .46 .51
ATP .86 .81 1.17 1.02 .64 .86 .62
KLA/ATP .35 .36 .47 .40 .46 .66 .43
H2-Aa
KLA  ATP  ATP+KLA
 NM_010378 histocompatibility 2, class II antigen A, alpha (H2-Aa), mRNA [NM_010378] KLA 1.43 1.59 1.68 1.50 1.62 1.89 1.64
ATP 1.07 1.15 1.27 1.90 1.92 1.77 1.55
KLA/ATP 1.62 1.81 1.74 2.29 1.89 1.92 2.19
H2-Ab1
KLA  ATP  ATP+KLA
 BC010322 histocompatibility 2, class II antigen A, beta 1, mRNA (cDNA clone MGC:6297 IMAGE:2651058), complete cds [BC010322] KLA 1.73 1.76 1.77 1.55 1.95 2.10 2.27
ATP 1.03 1.18 1.32 1.99 1.79 1.56 1.61
KLA/ATP 1.70 2.01 1.74 2.52 1.58 2.01 2.75
H2-Ab1
KLA  ATP  ATP+KLA
 NM_207105 histocompatibility 2, class II antigen A, beta 1 (H2-Ab1), mRNA [NM_207105] KLA 2.02 2.15 2.07 2.09 2.32 2.78 3.08
ATP 1.11 1.20 1.42 2.33 2.33 2.25 1.87
KLA/ATP 2.11 2.32 2.52 3.62 2.67 2.96 5.04
H2-Bl
KLA  ATP  ATP+KLA
 NM_008199 histocompatibility 2, blastocyst (H2-Bl), mRNA [NM_008199] KLA 1.29 1.32 1.40 1.28 1.36 1.46 1.80
ATP 1.04 1.11 1.02 1.34 1.28 1.32 1.47
KLA/ATP 1.32 1.39 1.34 1.77 1.41 1.61 2.39
H2-D1
KLA  ATP  ATP+KLA
 AK169750 2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:E430019E13 product:histocompatibility 2, D region locus 1, full insert sequence [AK169750] KLA .99 .98 .96 .99 .93 .91 .94
ATP .96 1.01 1.02 .95 1.05 1.00 .98
KLA/ATP .92 .94 .97 .97 .98 .92 1.03
H2-D1
KLA  ATP  ATP+KLA
 NM_010380 histocompatibility 2, D region locus 1 (H2-D1), mRNA [NM_010380] KLA 1.38 1.45 1.73 1.42 1.70 1.76 2.56
ATP 1.15 1.11 .86 1.12 1.19 1.28 1.90
KLA/ATP 1.58 1.72 1.38 1.56 1.38 1.69 3.21
H2-DMa
KLA  ATP  ATP+KLA
 NM_010386 histocompatibility 2, class II, locus DMa (H2-DMa), mRNA [NM_010386] KLA 1.49 1.50 1.65 1.65 1.91 2.23 1.69
ATP 1.04 1.12 1.26 1.67 1.24 .99 1.32
KLA/ATP 1.58 1.68 1.70 2.02 1.37 1.35 1.90
H2-DMb1
KLA  ATP  ATP+KLA
 NM_010387 histocompatibility 2, class II, locus Mb1 (H2-DMb1), mRNA [NM_010387] KLA 1.06 1.14 1.08 1.13 1.24 1.41 1.37
ATP 1.01 1.02 1.09 1.14 .92 .73 1.36
KLA/ATP 1.13 1.05 1.21 1.17 .98 .83 1.41
H2-DMb2
KLA  ATP  ATP+KLA
 NM_010388 histocompatibility 2, class II, locus Mb2 (H2-DMb2), mRNA [NM_010388] KLA 1.00 1.04 .93 .95 .96 .95 1.03
ATP 1.06 1.04 .94 .92 .97 .95 1.00
KLA/ATP .90 .94 .99 .94 .90 .96 .92
H2-Eb1
KLA  ATP  ATP+KLA
 X52641 gb|Mouse mRNA for I-A beta NOD. [X52641] KLA 1.94 2.06 1.94 1.87 1.96 2.18 1.76
ATP 1.11 1.20 1.53 2.70 3.02 2.91 1.40
KLA/ATP 2.09 2.11 2.26 3.55 2.76 3.05 3.05
H2-K1
KLA  ATP  ATP+KLA
 M69070 mRNA, complete cds. [M69070] KLA 1.76 1.66 1.78 1.78 1.87 2.23 2.99
ATP .98 .97 1.19 1.45 1.36 1.68 2.17
KLA/ATP 1.68 1.70 1.87 1.96 1.87 2.13 3.82
H2-K1
KLA  ATP  ATP+KLA
 NM_001001892 histocompatibility 2, K1, K region (H2-K1), transcript variant 1, mRNA [NM_001001892] KLA 1.82 1.66 1.73 1.76 1.87 2.29 3.17
ATP .98 .97 1.13 1.32 1.29 1.57 2.09
KLA/ATP 1.64 1.71 1.77 1.82 1.71 2.12 3.91
H2-M1
KLA  ATP  ATP+KLA
 NM_177636 histocompatibility 2, M region locus 1 (H2-M1), mRNA [NM_177636] KLA .99 1.01 1.02 1.02 .97 1.03 1.04
ATP 1.01 .99 1.03 1.07 .92 1.03 .98
KLA/ATP 1.08 .97 .94 1.04 1.00 1.04 1.02
H2-M10.1
KLA  ATP  ATP+KLA
 NM_013544 histocompatibility 2, M region locus 10.1 (H2-M10.1), mRNA [NM_013544] KLA 1.04 1.00 1.05 .95 .98 1.04 .94
ATP 1.06 1.04 .96 .95 .97 .98 .98
KLA/ATP 1.02 1.07 .98 1.02 .92 .92 .99
H2-M10.2
KLA  ATP  ATP+KLA
 NM_177923 histocompatibility 2, M region locus 10.2 (H2-M10.2), mRNA [NM_177923] KLA 2.18 2.23 2.51 2.61 2.90 3.30 3.40
ATP 1.08 1.02 1.22 1.39 1.30 1.56 2.66
KLA/ATP 2.23 2.53 2.82 2.91 2.89 2.60 3.92
H2-M10.3
KLA  ATP  ATP+KLA
 AY211080 major histocompatibility complex class Ib M10.3 mRNA, complete cds [AY211080] KLA .95 1.08 .99 .95 1.00 1.11 1.04
ATP .98 .96 1.00 .99 1.00 .99 1.00
KLA/ATP 1.00 .99 1.00 1.00 .99 .96 1.03
H2-M10.4
KLA  ATP  ATP+KLA
 NM_177634 histocompatibility 2, M region locus 10.4 (H2-M10.4), mRNA [NM_177634] KLA 1.03 1.04 1.08 1.08 1.04 1.03 1.03
ATP 1.07 1.05 .97 1.08 .95 .97 1.02
KLA/ATP 1.02 .97 1.02 .99 .93 1.06 1.04
H2-M10.5
KLA  ATP  ATP+KLA
 NM_177637 histocompatibility 2, M region locus 10.5 (H2-M10.5), mRNA [NM_177637] KLA 1.00 1.04 1.13 .93 .99 1.00 1.07
ATP 1.02 1.02 1.04 .90 1.03 .99 .99
KLA/ATP 1.06 1.03 .97 1.03 1.03 .98 1.04
H2-M10.6
KLA  ATP  ATP+KLA
 NM_201611 histocompatibility 2, M region locus 10.6 (H2-M10.6), mRNA [NM_201611] KLA 1.06 .99 1.04 1.06 .98 1.03 .92
ATP 1.04 1.09 .96 .98 .94 1.07 .98
KLA/ATP 1.01 1.06 1.02 .96 .96 1.04 1.05
H2-M11
KLA  ATP  ATP+KLA
 NM_177635 histocompatibility 2, M region locus 11 (H2-M11), mRNA [NM_177635] KLA 1.03 1.07 1.06 1.02 .96 1.05 1.03
ATP 1.02 .96 1.08 .98 1.04 .94 .98
KLA/ATP 1.03 1.03 .99 1.01 1.01 .98 .99
H2-M3
KLA  ATP  ATP+KLA
 NM_013819 histocompatibility 2, M region locus 3 (H2-M3), mRNA [NM_013819] KLA 1.90 2.04 2.09 2.37 2.30 2.56 2.73
ATP 1.00 1.00 1.19 1.34 1.00 .70 1.09
KLA/ATP 1.77 1.94 2.37 2.49 1.89 1.67 2.06
H2-M9
KLA  ATP  ATP+KLA
 NM_008205 histocompatibility 2, M region locus 9 (H2-M9), mRNA [NM_008205] KLA 1.03 .99 .96 .98 1.01 .99 1.03
ATP .96 1.06 .94 .96 1.05 1.06 1.00
KLA/ATP .96 1.01 1.01 .99 .97 .95 .98
H2-Oa
KLA  ATP  ATP+KLA
 NM_008206 histocompatibility 2, O region alpha locus (H2-Oa), mRNA [NM_008206] KLA 1.22 1.32 1.37 1.33 1.31 1.26 1.53
ATP 1.02 1.05 1.16 1.21 1.12 1.07 1.16
KLA/ATP 1.32 1.34 1.31 1.34 1.25 1.35 2.78
H2-Ob
KLA  ATP  ATP+KLA
 NM_010389 histocompatibility 2, O region beta locus (H2-Ob), mRNA [NM_010389] KLA 1.05 1.07 1.01 .96 1.10 1.02 1.00
ATP 1.04 .99 1.00 1.03 .94 1.07 .94
KLA/ATP 1.02 .97 1.06 1.08 1.00 .96 1.05
H2-Q1
KLA  ATP  ATP+KLA
 NM_010390 histocompatibility 2, Q region locus 1 (H2-Q1), mRNA [NM_010390] KLA 1.05 1.08 1.03 1.02 .98 1.09 1.00
ATP .99 .92 .93 1.01 1.01 1.04 1.00
KLA/ATP 1.07 1.00 1.00 .91 .97 1.07 1.04
H2-Q10
KLA  ATP  ATP+KLA
 NM_010391 histocompatibility 2, Q region locus 10 (H2-Q10), mRNA [NM_010391] KLA 1.50 1.50 1.70 1.64 1.67 1.79 2.18
ATP 1.12 1.11 1.09 1.46 1.42 1.43 1.69
KLA/ATP 1.61 1.72 1.79 1.94 1.81 1.81 2.93
H2-Q2
KLA  ATP  ATP+KLA
 NM_010392 histocompatibility 2, Q region locus 2 (H2-Q2), mRNA [NM_010392] KLA 1.55 1.52 1.61 1.45 1.83 1.94 2.47
ATP 1.09 1.13 .92 1.16 1.17 1.30 1.88
KLA/ATP 1.55 1.70 1.58 1.80 1.64 1.87 3.43
H2-Q7
KLA  ATP  ATP+KLA
 NM_010394 histocompatibility 2, Q region locus 7 (H2-Q7), mRNA [NM_010394] KLA 1.57 1.58 1.74 1.55 1.82 2.00 2.76
ATP 1.05 1.09 .84 1.12 1.12 1.23 2.00
KLA/ATP 1.63 1.75 1.43 1.67 1.53 1.80 3.48
H2-Q8
KLA  ATP  ATP+KLA
 NM_023124 histocompatibility 2, Q region locus 8 (H2-Q8), mRNA [NM_023124] KLA 7.48 6.46 6.41 7.15 7.46 9.60 18.27
ATP 1.01 .98 1.48 2.05 1.93 3.83 8.26
KLA/ATP 6.72 7.10 9.11 10.95 10.71 12.88 31.43
H2-T22
KLA  ATP  ATP+KLA
 NM_010397 histocompatibility 2, T region locus 22 (H2-T22), mRNA [NM_010397] KLA 5.21 5.40 5.81 6.31 7.42 9.49 7.50
ATP 1.01 .95 .88 .92 .93 3.65 5.53
KLA/ATP 4.83 5.12 4.58 4.74 4.81 6.89 14.89
H2-T23
KLA  ATP  ATP+KLA
 NM_010398 histocompatibility 2, T region locus 23 (H2-T23), mRNA [NM_010398] KLA 1.83 1.80 1.92 1.86 2.32 2.56 3.43
ATP 1.03 1.08 .85 1.18 1.09 1.30 2.49
KLA/ATP 1.76 1.92 1.62 1.93 1.76 2.13 4.06
H2-T24
KLA  ATP  ATP+KLA
 NM_008207 histocompatibility 2, T region locus 24 (H2-T24), mRNA [NM_008207] KLA 3.02 3.26 4.14 4.26 5.15 6.06 5.89
ATP 1.08 1.09 1.32 1.35 1.17 1.71 6.71
KLA/ATP 3.23 3.31 3.54 3.85 3.07 3.73 9.10
H2-T3
KLA  ATP  ATP+KLA
 NM_008208 histocompatibility 2, T region locus 3 (H2-T3), mRNA [NM_008208] KLA .95 1.04 1.00 .97 .97 .99 1.00
ATP .98 1.08 1.03 1.01 .98 1.02 1.03
KLA/ATP 1.05 .96 1.02 1.04 1.05 1.00 .97
Hc
KLA  ATP  ATP+KLA
 NM_010406 hemolytic complement (Hc), mRNA [NM_010406] KLA 1.07 1.12 1.05 .98 1.12 1.12 1.08
ATP .96 .93 1.12 1.07 1.34 5.60 1.48
KLA/ATP 1.05 1.18 1.12 1.05 1.13 3.40 4.37
Hcfc1
KLA  ATP  ATP+KLA
 NM_008224 host cell factor C1 (Hcfc1), mRNA [NM_008224] KLA 1.04 1.03 1.05 .88 .98 1.00 1.25
ATP 1.05 1.12 .80 .76 .63 .83 .96
KLA/ATP 1.10 1.14 .74 .85 .63 .70 .87
Hcfc2
KLA  ATP  ATP+KLA
 AK040565 0 day neonate thymus cDNA, RIKEN full-length enriched library, clone:A430106M23 product:unclassifiable, full insert sequence [AK040565] KLA .81 .84 .84 .93 1.03 1.03 1.08
ATP .90 .95 .82 .50 .50 .50 .63
KLA/ATP .79 .79 .69 .57 .55 .45 .51
Hcfc2
KLA  ATP  ATP+KLA
 NM_001081218 host cell factor C2 (Hcfc2), mRNA [NM_001081218] KLA .94 .99 1.15 1.15 1.21 1.28 1.74
ATP .96 1.02 .86 .75 .58 .78 1.46
KLA/ATP .97 1.03 .92 .82 .69 .64 1.12
Hmgn1
KLA  ATP  ATP+KLA
 AK080436 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730012H23 product:unclassifiable, full insert sequence [AK080436] KLA .63 .62 .62 .67 .75 .70 .79
ATP .70 .61 .59 .70 .69 .69 .86
KLA/ATP .53 .49 .66 .67 .70 .66 .67
Hmgn1
KLA  ATP  ATP+KLA
 NM_008251 high mobility group nucleosomal binding domain 1 (Hmgn1), mRNA [NM_008251] KLA .61 .62 .55 .52 .48 .41 .32
ATP .90 .88 .91 .86 .77 .40 .36
KLA/ATP .57 .59 .53 .52 .48 .29 .14
Hnrpk
KLA  ATP  ATP+KLA
 BC089328 heterogeneous nuclear ribonucleoprotein K, mRNA (cDNA clone MGC:102032 IMAGE:6402614), complete cds [BC089328] KLA 1.05 1.04 .97 1.01 .99 .91 .81
ATP 1.04 1.11 1.08 1.11 1.09 .86 .74
KLA/ATP 1.02 .98 .86 .95 .91 .71 .56
Hnrpk
KLA  ATP  ATP+KLA
 NM_025279 heterogeneous nuclear ribonucleoprotein K (Hnrpk), mRNA [NM_025279] KLA 1.14 1.14 1.21 1.15 1.02 1.00 .91
ATP .93 1.13 1.22 1.16 1.06 .89 .87
KLA/ATP .99 1.24 1.34 1.17 .97 .91 .71
Ifih1
KLA  ATP  ATP+KLA
 NM_027835 interferon induced with helicase C domain 1 (Ifih1), mRNA [NM_027835] KLA 37.11 33.14 35.90 33.98 21.58 12.10 6.89
ATP 1.03 .97 .74 .73 1.20 4.28 2.92
KLA/ATP 33.28 36.92 27.96 24.80 12.35 8.39 10.11
Ifit1
KLA  ATP  ATP+KLA
 NM_008331 interferon-induced protein with tetratricopeptide repeats 1 (Ifit1), mRNA [NM_008331] KLA 135.72 113.87 103.77 80.36 56.00 83.83 37.35
ATP 1.04 .85 .94 .76 2.31 49.86 32.09
KLA/ATP 125.55 117.42 90.59 105.68 85.74 135.36 156.56
Ifna12
KLA  ATP  ATP+KLA
 NM_177361 interferon alpha 12 (Ifna12), mRNA [NM_177361] KLA 1.25 1.26 1.34 1.16 1.06 1.10 1.09
ATP 1.01 .97 1.07 1.09 1.17 1.20 1.07
KLA/ATP 1.12 1.29 1.72 1.54 1.59 1.56 1.05
Ifna13
KLA  ATP  ATP+KLA
 NM_177347 interferon alpha 13 (Ifna13), mRNA [NM_177347] KLA 1.32 1.27 1.26 1.34 1.15 1.24 1.20
ATP .95 1.08 1.29 1.79 1.41 1.22 1.08
KLA/ATP 1.36 1.35 2.04 2.81 2.07 1.44 1.19
Ifna2
KLA  ATP  ATP+KLA
 K01411 gb|Mouse alpha-interferon (MuIFN-alpha), 3 cds & untranslated mRNA [K01411] KLA 1.02 1.03 1.10 .96 .93 .99 1.01
ATP 1.02 .98 1.00 .98 1.02 .97 .95
KLA/ATP 1.02 1.04 1.18 1.08 1.13 1.04 1.01
Ifna2
KLA  ATP  ATP+KLA
 NM_010503 interferon alpha 2 (Ifna2), mRNA [NM_010503] KLA 1.08 1.06 1.07 1.06 .98 1.02 1.05
ATP .94 1.06 1.11 1.30 1.24 1.25 1.21
KLA/ATP 1.03 1.20 1.19 1.35 1.52 1.60 1.18
Ifna4
KLA  ATP  ATP+KLA
 NM_010504 interferon alpha 4 (Ifna4), mRNA [NM_010504] KLA .99 1.04 1.05 .97 1.00 .96 .99
ATP 1.01 .96 .98 1.01 1.00 1.00 .97
KLA/ATP 1.10 1.09 1.05 1.04 1.01 .97 1.01
Ifna5
KLA  ATP  ATP+KLA
 NM_010505 interferon alpha 5 (Ifna5), mRNA [NM_010505] KLA 1.15 1.23 1.51 1.26 1.03 1.06 1.05
ATP .99 .94 1.11 1.00 1.09 1.07 1.03
KLA/ATP 1.12 1.29 1.46 1.47 1.24 1.32 1.03
Ifna9
KLA  ATP  ATP+KLA
 NM_010507 interferon alpha 9 (Ifna9), mRNA [NM_010507] KLA 1.05 1.09 1.20 1.06 1.08 1.06 1.02
ATP .99 1.08 1.18 1.21 1.09 .99 .97
KLA/ATP 1.09 1.23 1.19 1.24 1.18 1.16 1.04
Ifnab
KLA  ATP  ATP+KLA
 BC116864 interferon alpha B, mRNA (cDNA clone MGC:151241 IMAGE:40126183), complete cds [BC116864] KLA 1.20 1.33 1.29 1.30 1.20 1.20 1.08
ATP .99 .99 1.00 1.25 1.13 1.19 1.04
KLA/ATP 1.30 1.39 1.44 1.48 1.49 1.54 1.22
Ifnar1
KLA  ATP  ATP+KLA
 NM_010508 interferon (alpha and beta) receptor 1 (Ifnar1), mRNA [NM_010508] KLA 1.35 1.29 1.19 1.39 1.60 1.47 1.49
ATP 1.18 1.25 .94 1.06 1.07 1.48 1.52
KLA/ATP 1.56 1.57 .98 1.43 1.08 1.79 3.54
Ifnar2
KLA  ATP  ATP+KLA
 NM_010509 interferon (alpha and beta) receptor 2 (Ifnar2), transcript variant 1, mRNA [NM_010509] KLA 1.45 1.43 1.67 1.87 2.31 1.84 1.36
ATP .99 .92 .87 1.03 1.38 1.79 1.43
KLA/ATP 1.48 1.48 1.24 1.54 1.77 2.10 2.81
Ifnb1
KLA  ATP  ATP+KLA
 NM_010510 interferon beta 1, fibroblast (Ifnb1), mRNA [NM_010510] KLA 49.82 46.57 34.05 16.05 5.94 7.31 8.49
ATP .99 1.02 1.89 4.78 6.31 4.44 1.79
KLA/ATP 49.22 61.83 134.08 144.05 110.96 31.78 11.24
Ifng
KLA  ATP  ATP+KLA
 NM_008337 interferon gamma (Ifng), mRNA [NM_008337] KLA 1.05 1.02 1.01 1.01 1.01 1.04 1.00
ATP 1.00 1.01 1.01 .98 .97 1.04 1.03
KLA/ATP 1.01 1.01 1.06 1.10 1.24 1.10 1.04
Ifngr1
KLA  ATP  ATP+KLA
 NM_010511 interferon gamma receptor 1 (Ifngr1), mRNA [NM_010511] KLA .81 .60 .37 .35 .34 .39 .54
ATP 1.05 .96 1.15 .97 .80 .67 .45
KLA/ATP .57 .57 .63 .36 .28 .33 .36
Ifngr2
KLA  ATP  ATP+KLA
 NM_008338 interferon gamma receptor 2 (Ifngr2), mRNA [NM_008338] KLA 1.45 1.49 1.74 2.22 3.22 2.42 1.96
ATP 1.11 1.03 .81 .78 1.12 1.28 1.34
KLA/ATP 1.48 1.41 1.17 1.23 1.48 1.89 2.13
Ikbkb
KLA  ATP  ATP+KLA
 NM_010546 inhibitor of kappaB kinase beta (Ikbkb), mRNA [NM_010546] KLA 1.88 2.10 2.14 1.83 1.73 1.31 1.19
ATP .81 .74 .55 .49 .59 1.05 .96
KLA/ATP 1.86 1.73 1.39 1.12 .89 1.17 1.24
Ikbke
KLA  ATP  ATP+KLA
 NM_019777 inhibitor of kappaB kinase epsilon (Ikbke), mRNA [NM_019777] KLA 6.03 5.91 6.38 6.89 7.05 6.70 4.74
ATP 1.02 1.11 .82 1.16 1.18 2.08 1.90
KLA/ATP 6.04 6.71 5.69 5.30 2.49 2.33 5.43
Ikbkg
KLA  ATP  ATP+KLA
 AK042138 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630062P04 product:unclassifiable, full insert sequence. [AK042138] KLA .92 .87 .78 .78 .87 .88 .62
ATP .84 .71 .80 .50 1.15 2.33 .61
KLA/ATP .72 .69 .74 .48 1.06 1.97 .68
Ikbkg
KLA  ATP  ATP+KLA
 NM_010547 inhibitor of kappaB kinase gamma (Ikbkg), transcript variant 1, mRNA [NM_010547] KLA 1.51 1.63 1.74 1.83 1.83 1.73 1.72
ATP .80 .79 .82 .75 .66 2.58 2.37
KLA/ATP 1.43 1.42 1.17 1.04 .71 1.54 3.17
Ikbkg
KLA  ATP  ATP+KLA
 NM_178590 inhibitor of kappaB kinase gamma (Ikbkg), transcript variant 2, mRNA [NM_178590] KLA .84 .93 .86 .91 1.03 .89 .88
ATP 1.03 .98 .68 .56 .51 .93 .68
KLA/ATP .89 .81 .55 .52 .41 .67 .65
Il12a
KLA  ATP  ATP+KLA
 NM_008351 interleukin 12a (Il12a), mRNA [NM_008351] KLA 2.37 2.47 2.17 1.49 1.46 1.12 1.20
ATP 1.01 .97 1.12 1.07 1.02 1.07 1.06
KLA/ATP 2.01 2.76 2.54 1.70 1.08 1.10 1.27
Il12b
KLA  ATP  ATP+KLA
 NM_008352 interleukin 12b (Il12b), mRNA [NM_008352] KLA 194.79 211.32 198.97 173.01 142.24 40.28 3.10
ATP 1.05 1.10 1.59 1.99 2.71 2.72 1.52
KLA/ATP 191.27 223.23 280.10 224.29 183.03 68.43 10.69
Il15
KLA  ATP  ATP+KLA
 AB022307 mRNA for shorter isoform of interleukin 15, partial cds. [AB022307] KLA 13.11 12.14 12.05 8.72 4.50 3.62 1.70
ATP 1.04 1.05 1.94 1.72 1.74 3.48 1.69
KLA/ATP 13.23 13.71 21.01 21.43 21.51 10.85 4.55
Il15
KLA  ATP  ATP+KLA
 NM_008357 interleukin 15 (Il15), mRNA [NM_008357] KLA 28.44 24.75 23.34 20.83 11.02 7.27 2.51
ATP 1.00 .96 1.22 1.21 1.24 4.27 1.85
KLA/ATP 24.24 23.93 33.47 31.76 21.73 10.79 11.23
Il1b
KLA  ATP  ATP+KLA
 NM_008361 interleukin 1 beta (Il1b), mRNA [NM_008361] KLA 149.78 133.59 100.91 116.58 86.48 89.37 64.72
ATP 3.49 13.96 61.44 70.91 82.12 162.79 28.18
KLA/ATP 130.32 139.00 219.12 148.17 165.44 172.57 146.98
Il6
KLA  ATP  ATP+KLA
 NM_031168 interleukin 6 (Il6), mRNA [NM_031168] KLA 352.99 378.70 276.81 168.47 59.99 18.66 8.27
ATP 1.04 1.08 2.28 3.69 30.40 161.93 2.11
KLA/ATP 334.28 528.66 ###.## 935.86 302.45 355.36 99.65
Irf3
KLA  ATP  ATP+KLA
 ENSMUST00000107835 ens|Interferon regulatory factor 3 (IRF-3). [Source:Uniprot/SWISSPROT;Acc:P70671] [ENSMUST00000107835] KLA .55 .56 .60 .72 .88 .88 .98
ATP .77 .58 .50 .46 .80 .97 1.03
KLA/ATP .51 .46 .49 .53 .92 .85 .79
Irf3
KLA  ATP  ATP+KLA
 NM_016849 interferon regulatory factor 3 (Irf3), mRNA [NM_016849] KLA .79 .75 .71 .83 .88 1.07 .99
ATP .92 .84 .88 .61 .54 1.27 1.22
KLA/ATP .78 .78 .75 .58 .70 1.13 1.38
Irf7
KLA  ATP  ATP+KLA
 NM_016850 interferon regulatory factor 7 (Irf7), mRNA [NM_016850] KLA 4.90 4.72 5.85 5.82 7.67 10.64 15.44
ATP 1.14 1.10 .86 1.18 .96 2.46 12.17
KLA/ATP 5.41 5.22 4.15 6.29 5.31 9.74 29.08
Irf9
KLA  ATP  ATP+KLA
 NM_008394 interferon regulatory factor 9 (Irf9), mRNA [NM_008394] KLA 1.96 1.99 2.13 1.83 1.81 1.85 1.71
ATP 1.08 1.06 .96 1.19 1.21 2.33 2.42
KLA/ATP 2.31 2.30 1.92 2.85 2.29 3.20 4.37
Jak1
KLA  ATP  ATP+KLA
 AK029232 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4831433J01 product:Janus kinase 1, full insert sequence. [AK029232] KLA 1.25 1.13 1.19 1.31 1.24 1.17 1.14
ATP 1.01 1.11 .96 1.38 1.06 1.26 1.05
KLA/ATP 1.19 1.29 1.27 1.59 1.18 1.38 1.24
Jak1
KLA  ATP  ATP+KLA
 NM_146145 Janus kinase 1 (Jak1), mRNA [NM_146145] KLA 1.71 1.75 1.79 1.81 1.72 1.37 1.21
ATP 1.03 1.01 .75 1.04 1.32 1.90 1.14
KLA/ATP 1.84 1.73 1.49 2.07 2.01 1.83 1.68
Jak2
KLA  ATP  ATP+KLA
 NM_008413 Janus kinase 2 (Jak2), transcript variant 1, mRNA [NM_008413] KLA 14.86 15.05 15.42 14.15 11.46 8.81 5.47
ATP .99 1.06 1.09 1.43 2.83 4.71 1.62
KLA/ATP 13.77 14.74 14.94 12.97 7.53 9.34 9.17
Jun
KLA  ATP  ATP+KLA
 NM_010591 Jun oncogene (Jun), mRNA [NM_010591] KLA 1.08 .96 1.09 1.09 .75 .88 .81
ATP 1.26 1.48 4.45 8.73 4.02 1.16 1.99
KLA/ATP 1.12 1.38 3.52 5.17 3.32 .49 1.42
LOC10004
6483
KLA  ATP  ATP+KLA
 XM_001476285 ref|PREDICTED: Mus musculus similar to casein kinase II, alpha prime subunit (LOC100046483), mRNA [XM_001476285] KLA .97 .94 .94 .88 .84 .76 .88
ATP 1.06 1.04 .89 .82 .87 .70 .56
KLA/ATP 1.03 1.00 .88 .75 .73 .66 .43
LOC10004
6898
KLA  ATP  ATP+KLA
 XM_001478127 ref|PREDICTED: Mus musculus similar to Cell division cycle 34 homolog (S. cerevisiae) (LOC100046898), mRNA [XM_001478127] KLA .71 .72 .78 .85 .71 .80 1.09
ATP .98 .90 1.10 .94 .87 .72 .67
KLA/ATP .78 .69 .80 .77 .80 .82 .66
LOC67670
8
KLA  ATP  ATP+KLA
 XM_992322 ref|PREDICTED: Mus musculus similar to class I (Qa) Q2k antigen (LOC676708), mRNA [XM_992322] KLA 2.18 2.22 2.32 2.27 2.28 2.77 3.62
ATP 1.04 1.17 1.17 2.19 1.83 1.75 2.30
KLA/ATP 2.20 2.44 2.25 3.41 2.30 2.63 5.00
Lta
KLA  ATP  ATP+KLA
 NM_010735 lymphotoxin A (Lta), mRNA [NM_010735] KLA 1.95 2.18 2.41 2.18 2.50 2.26 1.79
ATP 1.01 1.00 1.10 1.55 1.24 1.09 1.07
KLA/ATP 2.16 2.23 1.85 2.11 1.60 1.31 1.33
Map3k7
KLA  ATP  ATP+KLA
 NM_172688 mitogen-activated protein kinase kinase kinase 7 (Map3k7), mRNA [NM_172688] KLA 1.48 1.49 1.51 1.24 1.21 1.19 1.61
ATP 1.10 1.16 1.03 1.03 1.12 1.61 1.61
KLA/ATP 1.43 1.56 1.05 1.15 .85 1.48 1.76
Map3k7ip
1
KLA  ATP  ATP+KLA
 NM_025609 mitogen-activated protein kinase kinase kinase 7 interacting protein 1 (Map3k7ip1), mRNA [NM_025609] KLA .32 .30 .35 .56 .67 .82 .76
ATP .95 .81 .80 .42 .35 .40 .80
KLA/ATP .33 .30 .37 .20 .45 .62 .65
Map3k7ip
2
KLA  ATP  ATP+KLA
 AK086230 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930015C19 product:inferred: Mus musculus, Similar to TAK1-binding protein 2; KIAA0733 protein, clone MGC:8010 IMAGE:3586132, mRNA, complete cds, full insert sequence. [A KLA 1.14 1.02 1.07 1.03 1.13 1.02 .96
ATP 1.00 .88 .92 .90 1.06 .96 .94
KLA/ATP 1.05 1.00 .90 .98 1.02 .97 .97
Map3k7ip
2
KLA  ATP  ATP+KLA
 NM_138667 mitogen-activated protein kinase kinase kinase 7 interacting protein 2 (Map3k7ip2), mRNA [NM_138667] KLA 3.43 3.22 3.19 2.41 2.13 1.51 1.10
ATP 1.08 1.08 .86 .81 1.30 1.32 1.02
KLA/ATP 3.34 3.66 3.00 2.58 1.80 1.52 1.61
Mapk10
KLA  ATP  ATP+KLA
 AK076990 adult male testis cDNA, RIKEN full-length enriched library, clone:4930597C01 product:mitogen activated protein kinase 10, full insert sequence. [AK076990] KLA 1.03 1.05 .98 1.04 .94 .95 1.02
ATP 1.00 .99 1.06 .97 1.01 .96 .99
KLA/ATP 1.07 1.01 .95 1.05 .82 .95 .87
Mapk10
KLA  ATP  ATP+KLA
 NM_009158 mitogen-activated protein kinase 10 (Mapk10), transcript variant 1, mRNA [NM_009158] KLA .95 1.00 .97 1.01 .99 1.01 .95
ATP 1.01 1.02 .98 1.01 1.04 1.01 .99
KLA/ATP 1.05 .99 1.01 .98 .92 .97 .98
Mapk8
KLA  ATP  ATP+KLA
 AK162915 adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330031O19 product:mitogen activated protein kinase 8, full insert sequence [AK162915] KLA .94 .86 .80 .83 .77 .85 .83
ATP 1.08 1.12 .94 .80 .83 .71 .75
KLA/ATP .83 .81 .80 .74 .74 .75 .67
Mapk8
KLA  ATP  ATP+KLA
 AK163829 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130070A06 product:mitogen activated protein kinase 8, full insert sequence [AK163829] KLA .65 .61 .66 .70 .90 1.02 1.03
ATP .99 .94 1.68 1.44 1.75 1.84 1.10
KLA/ATP .63 .67 1.11 1.00 2.01 1.68 1.15
Mapk8
KLA  ATP  ATP+KLA
 NM_016700 mitogen-activated protein kinase 8 (Mapk8), mRNA [NM_016700] KLA .96 1.00 .94 .96 .94 .99 1.04
ATP 1.01 1.05 1.01 .99 1.03 .98 1.02
KLA/ATP .96 .97 .96 .97 .93 .94 .96
Mapk9
KLA  ATP  ATP+KLA
 NM_016961 mitogen-activated protein kinase 9 (Mapk9), transcript variant 2, mRNA [NM_016961] KLA 1.28 1.37 1.59 1.60 1.61 1.43 1.38
ATP 1.03 .99 .74 .71 .79 1.20 1.01
KLA/ATP 1.53 1.30 1.07 .99 .83 1.10 1.40
Mapk9
KLA  ATP  ATP+KLA
 NM_207692 mitogen-activated protein kinase 9 (Mapk9), transcript variant 1, mRNA [NM_207692] KLA 1.39 1.53 1.69 1.69 1.55 1.44 1.51
ATP .95 .92 .75 .85 .70 1.46 1.17
KLA/ATP 1.37 1.35 .99 1.18 .91 1.22 1.62
Mcrs1
KLA  ATP  ATP+KLA
 NM_016766 microspherule protein 1 (Mcrs1), mRNA [NM_016766] KLA 1.27 1.31 1.35 1.36 1.45 1.19 1.01
ATP .96 .99 .80 .83 .69 1.10 .89
KLA/ATP 1.28 1.18 1.04 1.10 .96 1.36 1.09
Med8
KLA  ATP  ATP+KLA
 NM_173719 mediator of RNA polymerase II transcription, subunit 8 homolog (yeast) (Med8), transcript variant 2, mRNA [NM_173719] KLA 1.07 1.22 1.13 1.29 1.43 1.51 1.50
ATP .89 .85 .74 .67 .67 1.25 1.17
KLA/ATP 1.02 1.00 1.00 .91 .87 1.09 1.29
Mm.12136
1
KLA  ATP  ATP+KLA
 144922673 Unknown KLA .57 .51 .45 .48 .64 .77 .35
ATP 1.08 1.09 .83 .61 .53 .51 .23
KLA/ATP .54 .53 .63 .53 .63 .54 .21
Mm.14301
KLA  ATP  ATP+KLA
 21630282 Unknown KLA 3.97 3.92 3.89 4.78 4.16 4.22 3.83
ATP .97 .93 1.27 1.16 1.01 2.62 4.12
KLA/ATP 3.93 4.01 4.75 4.44 4.41 3.51 5.56
Mm.19506
1
KLA  ATP  ATP+KLA
 76253707 Unknown KLA 5.35 4.83 5.36 6.20 6.87 9.80 7.83
ATP .97 .90 .96 .77 .80 3.98 5.87
KLA/ATP 4.63 4.51 4.51 3.75 4.39 7.21 16.38
Mm.23692
KLA  ATP  ATP+KLA
 164565453 Unknown KLA .83 .77 .72 .65 .61 .75 .80
ATP .77 .94 1.03 .63 .61 .74 .59
KLA/ATP .58 .78 .77 .52 .51 .56 .30
Mm.24042
KLA  ATP  ATP+KLA
 142366948 Unknown KLA .70 .66 .55 .53 .54 .62 .39
ATP .91 .84 1.19 .96 1.32 1.49 .31
KLA/ATP .63 .61 .82 .83 1.11 1.28 .19
Mm.24936
4
KLA  ATP  ATP+KLA
 133892283 Unknown KLA 1.42 1.41 1.61 2.14 2.88 2.49 2.03
ATP .98 .98 .76 .77 1.09 1.23 1.28
KLA/ATP 1.32 1.32 1.07 1.12 1.38 1.85 1.95
Mm.31223
3
KLA  ATP  ATP+KLA
 149269666 Unknown KLA 1.09 1.05 1.09 .97 .85 .87 .88
ATP .92 1.01 1.10 1.32 1.22 1.01 .87
KLA/ATP 1.05 1.08 1.06 1.10 1.08 .89 .83
Mm.33273
5
KLA  ATP  ATP+KLA
 125625330 Unknown KLA .33 .30 .33 .39 .42 .46 .55
ATP .93 .94 1.52 1.18 .83 .75 .70
KLA/ATP .28 .30 .47 .40 .59 .45 .32
Mm.33509
6
KLA  ATP  ATP+KLA
 40254533 Unknown KLA .68 .70 .59 .64 .45 .52 .51
ATP .99 1.04 1.00 .80 1.26 1.55 .86
KLA/ATP .68 .74 .66 .70 1.21 1.77 .77
Mm.33624
4
KLA  ATP  ATP+KLA
 158508452 Unknown KLA 1.01 1.08 .97 .96 1.00 .96 .92
ATP .95 .99 .98 .99 .97 1.01 1.03
KLA/ATP .95 .96 1.08 .97 .97 .96 .97
Mm.35584
KLA  ATP  ATP+KLA
 70909358 Unknown KLA .22 .25 .28 .33 .40 .77 .46
ATP 1.05 .96 1.08 .56 1.10 .79 .74
KLA/ATP .23 .25 .32 .25 .90 1.02 .60
Mm.37195
6
KLA  ATP  ATP+KLA
 94405889 Unknown KLA 57.25 49.51 48.65 57.96 50.90 57.18 41.44
ATP 1.02 .90 1.21 1.10 2.19 27.45 33.37
KLA/ATP 48.99 49.58 73.18 63.02 73.34 72.06 76.66
Mm.37708
7
KLA  ATP  ATP+KLA
 158631169 Unknown KLA .98 .98 1.06 1.06 .91 .97 1.04
ATP 1.00 1.07 1.01 1.06 1.09 .99 1.02
KLA/ATP 1.08 1.06 1.16 1.11 1.16 1.12 1.04
Mm.37899
0
KLA  ATP  ATP+KLA
 144227203 Unknown KLA 5.51 4.67 4.55 6.22 4.34 4.26 2.87
ATP 1.00 .76 .68 .41 .53 3.65 1.93
KLA/ATP 4.53 4.63 5.45 2.73 3.51 4.58 3.75
Mm.4341
KLA  ATP  ATP+KLA
 31982076 Unknown KLA 15.21 12.82 10.30 10.79 6.76 4.53 2.96
ATP 1.06 .90 .81 .46 .58 1.71 .85
KLA/ATP 11.00 11.87 16.67 9.82 6.57 3.88 2.71
Mm.43665
0
KLA  ATP  ATP+KLA
 119226248 Unknown KLA 1.08 1.00 1.01 1.00 .95 .95 1.00
ATP 1.06 1.04 1.01 .95 1.02 .97 1.00
KLA/ATP 1.06 1.00 1.01 .96 1.01 .97 .93
Mm.43967
5
KLA  ATP  ATP+KLA
 133778954 Unknown KLA 1.76 1.74 1.70 1.72 1.75 2.14 3.19
ATP 1.00 1.01 1.18 1.28 1.25 1.48 1.84
KLA/ATP 1.67 1.64 1.70 1.79 1.63 2.04 3.36
Mm.43967
5
KLA  ATP  ATP+KLA
 149275074 Unknown KLA 2.17 2.23 2.26 2.58 2.26 2.10 1.43
ATP .96 .91 1.12 .90 .70 1.10 1.47
KLA/ATP 1.96 2.10 1.92 1.51 1.12 1.35 1.99
Mm.43973
7
KLA  ATP  ATP+KLA
 110624769 Unknown KLA 1.37 1.42 1.33 1.29 1.33 1.39 1.52
ATP 1.00 1.08 1.15 1.51 1.42 1.32 1.59
KLA/ATP 1.44 1.48 1.35 1.93 1.62 1.67 2.56
Mm.44165
1
KLA  ATP  ATP+KLA
 160333403 Unknown KLA 5.45 5.27 5.02 6.34 6.63 10.05 8.10
ATP .91 .84 .96 .75 .78 3.91 6.03
KLA/ATP 4.29 4.38 4.50 3.55 4.22 7.22 17.63
Mm.44889
KLA  ATP  ATP+KLA
 157057165 Unknown KLA 1.20 1.25 1.45 1.49 1.63 1.70 1.66
ATP 1.00 1.03 1.03 1.00 1.12 1.06 1.23
KLA/ATP 1.25 1.15 1.16 1.16 1.15 1.41 1.71
Mm.46002
4
KLA  ATP  ATP+KLA
 38348245 Unknown KLA 1.22 1.25 1.25 1.19 1.22 1.47 1.14
ATP 1.03 .94 1.01 1.01 2.67 2.31 1.37
KLA/ATP 1.35 1.19 1.27 1.22 1.99 1.83 1.45
Mm.5126
KLA  ATP  ATP+KLA
 158508678 Unknown KLA .70 .71 .73 .79 .87 1.11 1.25
ATP 1.22 1.37 1.08 1.54 1.38 1.01 1.26
KLA/ATP .85 .83 .75 .90 1.12 .96 1.17
Mm.57127
KLA  ATP  ATP+KLA
 117168292 Unknown KLA 1.20 1.25 1.28 1.18 1.14 1.13 1.12
ATP .98 .95 1.11 1.06 1.05 1.05 1.09
KLA/ATP 1.22 1.24 1.48 1.55 1.40 1.21 1.07
Mm.6787
KLA  ATP  ATP+KLA
 141803005 Unknown KLA 1.61 1.47 1.55 1.58 1.05 .84 .73
ATP .97 .75 1.10 .72 .49 .73 .36
KLA/ATP 1.50 1.31 1.60 1.03 .91 .64 .30
Mm.7373
KLA  ATP  ATP+KLA
 141803296 Unknown KLA .24 .24 .28 .55 .90 1.30 1.06
ATP 1.11 1.29 3.81 6.45 4.44 2.96 1.65
KLA/ATP .24 .31 1.21 3.13 8.41 4.94 2.50
Myd88
KLA  ATP  ATP+KLA
 NM_010851 myeloid differentiation primary response gene 88 (Myd88), mRNA [NM_010851] KLA 3.35 3.51 3.91 4.13 4.13 3.62 2.53
ATP .99 .96 .79 .75 .93 2.15 1.60
KLA/ATP 3.37 3.52 3.52 3.48 2.81 3.03 3.33
Nfkb1
KLA  ATP  ATP+KLA
 BC050841 nuclear factor of kappa light chain gene enhancer in B-cells 1, p105, mRNA (cDNA clone IMAGE:6392793), complete cds. [BC050841] KLA 5.81 4.96 4.77 3.21 3.37 2.00 1.71
ATP 1.39 1.52 3.25 12.63 13.64 4.80 1.08
KLA/ATP 7.21 8.69 19.53 23.93 11.70 2.85 2.01
Nfkb1
KLA  ATP  ATP+KLA
 M57999 gb|Mouse transcription factor NF-kappa-B DNA binding subunit mRNA, complete cds. [M57999] KLA 8.55 7.87 7.35 6.13 3.51 1.85 1.38
ATP .98 .96 1.21 3.06 5.29 4.67 .69
KLA/ATP 7.32 7.20 8.71 10.82 5.55 2.77 1.54
Nfkbia
KLA  ATP  ATP+KLA
 NM_010907 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (Nfkbia), mRNA [NM_010907] KLA 18.65 18.46 13.63 17.88 14.25 9.17 7.92
ATP .91 1.09 7.11 32.39 17.44 10.49 1.72
KLA/ATP 15.57 17.66 15.73 23.91 13.83 10.73 9.48
Nfkbib
KLA  ATP  ATP+KLA
 NM_010908 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta (Nfkbib), mRNA [NM_010908] KLA 4.63 4.69 4.36 4.27 4.23 2.52 2.17
ATP 1.11 1.22 1.55 4.23 4.93 3.66 1.76
KLA/ATP 4.71 5.41 4.58 7.08 6.20 4.73 4.11
Nxf1
KLA  ATP  ATP+KLA
 NM_016813 nuclear RNA export factor 1 homolog (S. cerevisiae) (Nxf1), mRNA [NM_016813] KLA 2.56 2.72 2.83 1.97 1.27 1.06 1.10
ATP 1.00 1.13 1.32 2.04 1.64 1.48 1.15
KLA/ATP 2.81 2.91 2.72 4.35 2.42 1.54 1.32
Nxf2
KLA  ATP  ATP+KLA
 NM_031259 nuclear RNA export factor 2 (Nxf2), mRNA [NM_031259] KLA .95 .97 .90 1.00 .91 .90 1.04
ATP 1.04 1.07 .99 1.02 .87 .89 .95
KLA/ATP .94 .89 .88 .95 .85 .90 .85
Nxf3
KLA  ATP  ATP+KLA
 NM_001024141 nuclear RNA export factor 3 (Nxf3), mRNA [NM_001024141] KLA .95 1.03 1.02 1.04 .95 .96 .98
ATP 1.09 .96 1.01 1.01 .95 .96 1.05
KLA/ATP 1.05 1.07 1.08 1.07 .95 1.00 .94
Nxf7
KLA  ATP  ATP+KLA
 NM_130888 nuclear RNA export factor 7 (Nxf7), mRNA [NM_130888] KLA 1.06 .97 .99 1.02 .98 .96 .94
ATP 1.01 1.06 1.04 .95 .99 1.01 .99
KLA/ATP .95 1.01 .97 .95 .94 .93 1.10
Oas1a
KLA  ATP  ATP+KLA
 NM_145211 2-5 oligoadenylate synthetase 1A (Oas1a), mRNA [NM_145211] KLA 2.26 2.33 2.50 2.33 3.11 3.74 3.99
ATP .99 1.04 .93 1.03 .91 1.63 3.44
KLA/ATP 2.49 2.39 1.91 2.51 2.28 3.09 6.06
Oas1b
KLA  ATP  ATP+KLA
 NM_001083925 2-5 oligoadenylate synthetase 1B (Oas1b), mRNA [NM_001083925] KLA 3.54 3.55 4.22 4.22 4.93 5.27 4.14
ATP 1.13 1.08 1.05 1.19 1.06 2.13 2.67
KLA/ATP 3.53 3.76 3.24 5.16 4.36 4.05 7.31
Oas1g
KLA  ATP  ATP+KLA
 NM_011852 2-5 oligoadenylate synthetase 1G (Oas1g), mRNA [NM_011852] KLA 2.58 2.75 2.53 2.84 2.60 2.74 2.56
ATP .97 1.03 1.20 1.17 1.07 1.82 2.47
KLA/ATP 2.58 2.80 2.68 2.60 2.21 2.27 3.01
Oas2
KLA  ATP  ATP+KLA
 NM_145227 2-5 oligoadenylate synthetase 2 (Oas2), mRNA [NM_145227] KLA 3.37 3.26 3.43 2.80 3.59 3.57 2.15
ATP 1.10 1.20 1.04 .86 .94 3.23 3.09
KLA/ATP 3.85 3.75 3.15 3.70 4.00 5.52 7.31
Oas3
KLA  ATP  ATP+KLA
 NM_145226 2-5 oligoadenylate synthetase 3 (Oas3), mRNA [NM_145226] KLA 2.32 2.35 2.67 2.63 3.37 3.80 4.07
ATP 1.06 1.10 1.02 1.26 1.02 1.47 3.58
KLA/ATP 2.62 2.57 2.39 3.18 2.67 3.05 6.15
OTTMUSG0
0000016644
KLA  ATP  ATP+KLA
 NM_001110517 predicted gene, OTTMUSG00000016644 (OTTMUSG00000016644), transcript variant 1, mRNA [NM_001110517] KLA 111.73 107.32 111.47 133.12 110.94 145.92 83.83
ATP 1.00 .93 1.20 1.40 1.93 24.54 43.21
KLA/ATP 99.78 116.52 147.75 125.04 144.55 182.77 171.34
Per1
KLA  ATP  ATP+KLA
 NM_011065 period homolog 1 (Drosophila) (Per1), mRNA [NM_011065] KLA .34 .30 .37 .63 1.06 1.49 1.15
ATP 1.16 1.43 3.32 7.74 4.34 2.71 1.69
KLA/ATP .34 .39 1.13 3.82 7.74 4.59 2.55
Per2
KLA  ATP  ATP+KLA
 NM_011066 period homolog 2 (Drosophila) (Per2), mRNA [NM_011066] KLA .81 .79 .76 .78 1.01 1.24 1.11
ATP 1.03 1.03 1.07 1.09 .98 1.23 .98
KLA/ATP .79 .75 .81 .81 1.03 1.15 .81
Per3
KLA  ATP  ATP+KLA
 NM_011067 period homolog 3 (Drosophila) (Per3), mRNA [NM_011067] KLA .97 .90 .84 .90 .96 .98 .71
ATP .97 1.04 1.01 .92 .94 .84 .67
KLA/ATP .91 .86 .78 .81 .90 .84 .58
Pilra
KLA  ATP  ATP+KLA
 AK041670 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630029C13 product:weakly similar to INHIBITORY RECEPTOR PILRALPHA [Homo sapiens], full insert sequence [AK041670] KLA 2.67 2.91 2.59 2.76 4.03 5.06 4.32
ATP 1.02 1.02 1.10 1.27 1.04 .87 .50
KLA/ATP 2.74 3.05 2.54 2.90 2.62 1.57 1.01
Pilra
KLA  ATP  ATP+KLA
 NM_153510 paired immunoglobin-like type 2 receptor alpha (Pilra), mRNA [NM_153510] KLA 1.99 2.08 2.04 2.18 3.13 4.24 4.31
ATP .97 1.06 1.10 1.54 1.32 1.00 .94
KLA/ATP 2.00 2.11 2.13 2.85 2.51 2.08 2.68
Pml
KLA  ATP  ATP+KLA
 NM_008884 promyelocytic leukemia (Pml), transcript variant 1, mRNA [NM_008884] KLA 5.73 6.01 7.28 6.76 5.85 5.36 2.28
ATP 1.07 1.10 .92 .89 .97 3.78 2.67
KLA/ATP 6.48 6.51 6.81 8.78 6.61 7.57 6.55
Polr2a
KLA  ATP  ATP+KLA
 NM_009089 polymerase (RNA) II (DNA directed) polypeptide A (Polr2a), mRNA [NM_009089] KLA 1.21 1.16 1.15 1.16 1.16 1.25 1.12
ATP 1.00 1.09 1.07 1.39 1.35 1.28 1.16
KLA/ATP 1.20 1.18 1.26 1.30 1.30 1.51 1.37
Pou2f3
KLA  ATP  ATP+KLA
 NM_011139 POU domain, class 2, transcription factor 3 (Pou2f3), mRNA [NM_011139] KLA 1.01 .95 1.02 1.05 .97 1.02 1.00
ATP .94 1.00 1.10 1.00 1.00 .99 1.03
KLA/ATP .98 1.02 1.00 .96 1.02 .90 .95
Ppp1ca
KLA  ATP  ATP+KLA
 NM_031868 protein phosphatase 1, catalytic subunit, alpha isoform (Ppp1ca), mRNA [NM_031868] KLA .89 .93 .93 .86 .95 1.07 1.20
ATP 1.04 1.07 .93 1.02 1.01 .89 1.10
KLA/ATP .98 .93 .74 .91 .84 1.01 1.34
Ppp1cb
KLA  ATP  ATP+KLA
 NM_172707 protein phosphatase 1, catalytic subunit, beta isoform (Ppp1cb), mRNA [NM_172707] KLA 1.12 1.08 1.05 1.02 .89 .84 .94
ATP .89 .87 .75 .55 .73 1.14 .69
KLA/ATP .92 .94 .80 .64 .64 .83 .65
Ppp1cc
KLA  ATP  ATP+KLA
 NM_013636 protein phosphatase 1, catalytic subunit, gamma isoform (Ppp1cc), mRNA [NM_013636] KLA .51 .51 .49 .48 .53 .64 .64
ATP 1.02 1.01 .85 .79 .72 .89 .95
KLA/ATP .54 .49 .42 .43 .56 .76 .81
Ptpn11
KLA  ATP  ATP+KLA
 NM_001109992 protein tyrosine phosphatase, non-receptor type 11 (Ptpn11), transcript variant 2, mRNA [NM_001109992] KLA 1.52 1.71 1.59 1.78 1.62 1.57 1.35
ATP 1.04 .93 .86 .79 1.09 1.95 1.90
KLA/ATP 1.59 1.61 1.45 1.11 1.18 1.82 3.02
Ptpn11
KLA  ATP  ATP+KLA
 NM_011202 protein tyrosine phosphatase, non-receptor type 11 (Ptpn11), transcript variant 1, mRNA [NM_011202] KLA 1.32 1.28 1.17 1.21 1.18 1.06 1.05
ATP .97 .77 .71 .56 .90 1.27 1.04
KLA/ATP 1.22 1.21 1.02 .70 .96 1.06 .94
Pvrl1
KLA  ATP  ATP+KLA
 NM_021424 poliovirus receptor-related 1 (Pvrl1), mRNA [NM_021424] KLA .69 .68 .57 .61 .46 .47 .49
ATP .97 .99 .94 .78 1.28 1.54 .89
KLA/ATP .70 .66 .69 .63 1.22 1.72 .81
Refbp2
KLA  ATP  ATP+KLA
 NM_019484 RNA and export factor binding protein 2 (Refbp2), mRNA [NM_019484] KLA 1.09 1.18 1.13 1.20 1.12 1.09 .84
ATP 1.02 1.07 1.07 1.66 1.44 1.03 .68
KLA/ATP 1.12 1.25 1.19 1.74 1.49 .94 .62
Rela
KLA  ATP  ATP+KLA
 NM_009045 v-rel reticuloendotheliosis viral oncogene homolog A (avian) (Rela), mRNA [NM_009045] KLA 2.05 2.05 2.07 1.75 1.83 1.58 1.33
ATP 1.03 1.08 1.10 1.44 1.61 2.48 1.05
KLA/ATP 2.17 2.27 2.05 2.47 1.93 2.35 2.02
Rnasel
KLA  ATP  ATP+KLA
 NM_011882 ribonuclease L (2, 5-oligoisoadenylate synthetase-dependent) (Rnasel), mRNA [NM_011882] KLA .25 .24 .26 .35 .50 .47 .31
ATP .98 .91 .60 .40 .36 1.12 .53
KLA/ATP .24 .25 .23 .22 .32 1.16 .52
Sfrs1
KLA  ATP  ATP+KLA
 NM_001078167 splicing factor, arginine/serine-rich 1 (ASF/SF2) (Sfrs1), transcript variant 2, mRNA [NM_001078167] KLA .75 .76 .66 .60 .57 .64 .73
ATP 1.06 1.10 .93 .82 .68 .72 .70
KLA/ATP .87 .71 .61 .60 .37 .37 .42
Sfrs1
KLA  ATP  ATP+KLA
 NM_173374 splicing factor, arginine/serine-rich 1 (ASF/SF2) (Sfrs1), transcript variant 1, mRNA [NM_173374] KLA 1.10 1.24 1.10 1.04 .80 .84 1.04
ATP .97 1.19 .95 1.43 .92 .94 .87
KLA/ATP 1.17 1.18 .97 1.24 .75 .76 .79
Sfrs2
KLA  ATP  ATP+KLA
 NM_011358 splicing factor, arginine/serine-rich 2 (SC-35) (Sfrs2), mRNA [NM_011358] KLA .73 .79 .69 .68 .96 1.39 .79
ATP 1.09 1.18 1.00 1.59 .94 .65 .84
KLA/ATP .74 .82 .60 1.18 .83 .73 .75
Sfrs2
KLA  ATP  ATP+KLA
 U14648 putative myelin regulatory factor 1 mRNA, partial cds. [U14648] KLA .62 .66 .59 .59 .82 1.27 .75
ATP .99 1.01 .96 1.26 .86 .58 .69
KLA/ATP .61 .64 .54 .85 .76 .68 .66
Sfrs3
KLA  ATP  ATP+KLA
 NM_013663 splicing factor, arginine/serine-rich 3 (SRp20) (Sfrs3), mRNA [NM_013663] KLA 1.54 1.52 1.30 1.45 1.06 .86 .70
ATP .96 .85 1.07 .65 .51 .74 .38
KLA/ATP 1.52 1.22 1.56 1.08 .84 .58 .34
Sfrs4
KLA  ATP  ATP+KLA
 NM_020587 splicing factor, arginine/serine-rich 4 (SRp75) (Sfrs4), mRNA [NM_020587] KLA 1.33 1.18 1.18 1.02 1.09 1.03 .91
ATP 1.06 1.00 .70 .80 1.35 1.34 .90
KLA/ATP 1.33 1.22 .85 .90 1.45 1.69 1.04
Sfrs5
KLA  ATP  ATP+KLA
 NM_001079695 splicing factor, arginine/serine-rich 5 (SRp40, HRS) (Sfrs5), transcript variant 1, mRNA [NM_001079695] KLA 1.38 1.62 1.21 1.26 1.95 1.98 .95
ATP .67 .64 .50 .45 .67 3.70 .90
KLA/ATP 1.28 1.23 1.01 .81 .86 2.20 1.22
Sfrs6
KLA  ATP  ATP+KLA
 AK004831 adult male lung cDNA, RIKEN full-length enriched library, clone:1210001E11 product:SPLICING FACTOR, ARGININE/SERINE-RICH 6 homolog [Homo sapiens], full insert sequence. [AK004831] KLA 1.05 1.09 .91 .69 .76 .79 1.01
ATP 1.06 1.01 .83 .70 .64 1.36 1.16
KLA/ATP 1.16 .99 .76 .72 .42 .83 .67
Sfrs7
KLA  ATP  ATP+KLA
 NM_146083 splicing factor, arginine/serine-rich 7 (Sfrs7), mRNA [NM_146083] KLA 1.39 1.34 1.35 1.29 1.09 .94 .74
ATP .93 .81 1.07 1.16 .90 1.29 .54
KLA/ATP 1.32 1.32 1.63 1.50 1.23 1.51 .53
Sfrs9
KLA  ATP  ATP+KLA
 NM_025573 splicing factor, arginine/serine rich 9 (Sfrs9), mRNA [NM_025573] KLA .63 .63 .60 .65 .86 1.19 1.07
ATP .97 1.01 .90 .91 .61 .61 .85
KLA/ATP .65 .72 .53 .54 .46 .54 .77
Skp1a
KLA  ATP  ATP+KLA
 NM_011543 S-phase kinase-associated protein 1A (Skp1a), mRNA [NM_011543] KLA 1.05 1.00 .92 .92 .88 .89 1.02
ATP .90 .98 1.21 1.43 1.32 1.46 1.09
KLA/ATP .93 1.01 1.11 1.31 1.21 1.27 1.21
Skp2
KLA  ATP  ATP+KLA
 AF083215 SCF complex protein Skp2 mRNA, complete cds. [AF083215] KLA .36 .37 .34 .37 .44 .78 .60
ATP 1.05 1.35 .85 .66 .83 .54 .76
KLA/ATP .33 .39 .37 .37 .65 .73 .62
Socs3
KLA  ATP  ATP+KLA
 NM_007707 suppressor of cytokine signaling 3 (Socs3), mRNA [NM_007707] KLA 7.56 6.68 6.29 7.36 6.47 7.03 5.33
ATP 1.51 1.75 4.63 6.27 6.92 7.74 4.64
KLA/ATP 6.82 6.77 9.19 8.32 9.51 8.98 8.33
Sp100
KLA  ATP  ATP+KLA
 BC028649 nuclear antigen Sp100, mRNA (cDNA clone IMAGE:964034). [BC028649] KLA 3.56 3.84 4.77 4.32 5.60 4.45 3.27
ATP 1.18 1.20 .87 1.22 .83 1.79 2.98
KLA/ATP 4.53 4.50 3.04 6.18 4.20 5.02 6.16
Sp100
KLA  ATP  ATP+KLA
 NM_013673 nuclear antigen Sp100 (Sp100), mRNA [NM_013673] KLA 2.97 3.03 3.21 3.06 3.44 3.09 2.62
ATP .96 .92 .95 1.02 .80 1.43 2.39
KLA/ATP 2.91 2.81 2.80 3.29 2.43 2.32 3.82
Srpk1
KLA  ATP  ATP+KLA
 NM_016795 serine/arginine-rich protein specific kinase 1 (Srpk1), mRNA [NM_016795] KLA 1.07 1.14 1.16 1.08 .95 .96 1.17
ATP 1.11 1.14 1.11 1.26 1.39 1.56 1.40
KLA/ATP 1.23 1.29 1.13 1.19 1.09 1.15 1.40
Stat1
KLA  ATP  ATP+KLA
 NM_009283 signal transducer and activator of transcription 1 (Stat1), mRNA [NM_009283] KLA 2.90 2.72 3.00 3.64 4.58 6.51 5.58
ATP 1.01 .92 .89 .72 .51 2.22 3.07
KLA/ATP 2.73 2.65 2.34 1.95 1.99 4.70 8.66
Stat2
KLA  ATP  ATP+KLA
 NM_019963 signal transducer and activator of transcription 2 (Stat2), mRNA [NM_019963] KLA 5.64 4.80 4.99 6.48 6.28 9.50 5.36
ATP .90 .80 1.03 .66 .97 4.90 4.07
KLA/ATP 4.47 4.88 6.34 4.27 6.76 9.49 11.43
Taf10
KLA  ATP  ATP+KLA
 NM_020024 TAF10 RNA polymerase II, TATA box binding protein (TBP)-associated factor (Taf10), mRNA [NM_020024] KLA .77 .81 .83 .74 .87 .89 1.21
ATP 1.02 1.12 1.01 1.39 1.06 .75 1.24
KLA/ATP .89 .90 .66 1.03 .78 .73 .97
Taf13
KLA  ATP  ATP+KLA
 NM_025444 TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor (Taf13), mRNA [NM_025444] KLA 1.24 1.20 1.13 1.30 1.08 1.26 .93
ATP 1.11 1.00 1.22 1.07 1.08 1.35 1.02
KLA/ATP 1.06 1.12 1.70 1.24 1.24 1.24 .92
Taf3
KLA  ATP  ATP+KLA
 AK030878 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830438I15 product:TAFII140 PROTEIN (FRAGMENT) homolog [Mus musculus], full insert sequence [AK030878] KLA .86 .96 .84 .84 .85 .88 1.04
ATP 1.10 1.11 1.09 .93 .84 .85 .85
KLA/ATP .98 .89 .85 .86 .88 .78 .71
Taf3
KLA  ATP  ATP+KLA
 NM_027748 TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor (Taf3), mRNA [NM_027748] KLA 1.11 1.15 1.04 1.02 .95 1.10 1.39
ATP 1.05 1.11 1.07 1.20 1.03 1.27 1.40
KLA/ATP 1.15 1.12 1.06 1.12 .92 1.26 1.56
Taf4a
KLA  ATP  ATP+KLA
 NM_001081092 TAF4A RNA polymerase II, TATA box binding protein (TBP)-associated factor (Taf4a), mRNA [NM_001081092] KLA .63 .66 .64 .71 .80 .93 .99
ATP 1.00 1.12 1.12 1.09 1.02 .85 .86
KLA/ATP .58 .64 .69 .74 .90 .87 .86
Taf4b
KLA  ATP  ATP+KLA
 XM_128905 gb|PREDICTED: Mus musculus TAF4B RNA polymerase II, TATA box binding protein (TBP)-associated factor (Taf4b), mRNA [XM_128905] KLA 1.06 1.10 .93 .95 .94 .99 1.04
ATP .96 1.01 1.38 1.94 1.58 1.01 .97
KLA/ATP 1.04 1.00 1.10 1.41 1.29 1.17 .94
Taf5
KLA  ATP  ATP+KLA
 NM_177342 TAF5 RNA polymerase II, TATA box binding protein (TBP)-associated factor (Taf5), mRNA [NM_177342] KLA .80 .80 .82 .71 .78 1.08 1.11
ATP 1.03 1.10 1.18 .96 1.68 1.26 .98
KLA/ATP .79 .77 .80 .74 1.51 1.22 .92
Taf5l
KLA  ATP  ATP+KLA
 NM_133966 TAF5-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor (Taf5l), mRNA [NM_133966] KLA .94 .95 .93 .89 .87 .90 1.08
ATP 1.05 .96 .88 .92 1.92 1.61 1.37
KLA/ATP .91 .97 .94 .80 1.63 1.61 .96
Taf6
KLA  ATP  ATP+KLA
 NM_009315 TAF6 RNA polymerase II, TATA box binding protein (TBP)-associated factor (Taf6), mRNA [NM_009315] KLA .78 .83 .93 .84 .77 1.04 1.03
ATP 1.05 1.08 .94 1.09 .63 .71 .97
KLA/ATP .81 .83 .79 .82 .62 .78 1.01
Taf6l
KLA  ATP  ATP+KLA
 NM_146092 TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor (Taf6l), mRNA [NM_146092] KLA .95 .90 .92 .80 .89 1.23 1.20
ATP 1.05 1.16 .96 1.18 .79 1.21 1.67
KLA/ATP 1.03 1.05 .83 1.00 .87 1.34 1.91
Taf9b
KLA  ATP  ATP+KLA
 NM_001001176 TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor (Taf9b), mRNA [NM_001001176] KLA .90 .98 .93 .89 .81 .75 .85
ATP 1.00 1.08 1.08 1.02 .80 .62 1.00
KLA/ATP .96 .94 .91 .92 .72 .62 .63
Tap1
KLA  ATP  ATP+KLA
 NM_013683 transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) (Tap1), mRNA [NM_013683] KLA 7.60 7.62 9.05 9.01 9.36 8.57 4.96
ATP 1.00 1.07 .96 1.13 .74 2.83 2.43
KLA/ATP 7.99 8.80 8.37 9.52 7.44 8.61 9.95
Tap2
KLA  ATP  ATP+KLA
 NM_011530 transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) (Tap2), mRNA [NM_011530] KLA 4.36 4.80 4.71 5.53 4.94 5.09 2.85
ATP .93 1.12 .97 1.20 1.38 2.30 2.20
KLA/ATP 4.15 5.22 6.03 6.07 5.60 5.42 6.52
Tbk1
KLA  ATP  ATP+KLA
 NM_019786 TANK-binding kinase 1 (Tbk1), mRNA [NM_019786] KLA 2.55 2.76 3.22 2.67 2.56 2.29 1.96
ATP 1.13 1.30 1.12 1.07 1.29 1.41 1.40
KLA/ATP 2.84 3.17 2.58 2.43 1.70 2.15 2.37
Tbp
KLA  ATP  ATP+KLA
 NM_013684 TATA box binding protein (Tbp), mRNA [NM_013684] KLA 1.27 1.33 1.42 1.17 1.23 1.20 1.22
ATP 1.07 1.21 1.01 .85 .93 1.04 1.14
KLA/ATP 1.38 1.40 1.13 1.11 .93 1.13 1.12
Tbpl1
KLA  ATP  ATP+KLA
 AK028621 10 days neonate skin cDNA, RIKEN full-length enriched library, clone:4732418P20 product:TATA box binding protein-like protein, full insert sequence [AK028621] KLA 1.03 1.11 .99 .98 .97 .88 .92
ATP .95 1.03 1.05 .94 .94 .96 1.09
KLA/ATP .98 .95 .99 .98 .98 1.03 1.01
Tbpl1
KLA  ATP  ATP+KLA
 NM_011603 TATA box binding protein-like 1 (Tbpl1), mRNA [NM_011603] KLA .68 .72 .72 .71 .76 .87 1.05
ATP .93 .97 .98 .89 1.05 .97 .85
KLA/ATP .67 .66 .74 .70 1.04 1.20 1.00
Tbpl2
KLA  ATP  ATP+KLA
 NM_199059 TATA box binding protein like 2 (Tbpl2), mRNA [NM_199059] KLA 1.01 1.10 .97 1.00 .92 .96 1.04
ATP 1.01 1.03 1.04 1.02 .95 1.00 1.02
KLA/ATP 1.04 .92 .83 1.06 1.03 1.02 .97
Thoc4
KLA  ATP  ATP+KLA
 NM_011568 THO complex 4 (Thoc4), mRNA [NM_011568] KLA .99 .96 .87 .99 .71 .60 .60
ATP .97 .92 1.37 1.52 1.35 1.09 .45
KLA/ATP .92 .98 1.09 1.27 1.31 .85 .29
Ticam1
KLA  ATP  ATP+KLA
 NM_174989 toll-like receptor adaptor molecule 1 (Ticam1), mRNA [NM_174989] KLA 1.45 1.63 2.02 2.36 3.12 2.34 2.21
ATP 1.16 1.19 .90 2.58 4.78 2.04 1.80
KLA/ATP 1.79 1.71 1.07 2.89 5.60 3.26 3.50
Tlr2
KLA  ATP  ATP+KLA
 NM_011905 toll-like receptor 2 (Tlr2), mRNA [NM_011905] KLA 13.65 11.82 8.87 7.95 4.67 2.78 2.33
ATP 1.06 1.24 2.76 6.28 11.55 13.82 .67
KLA/ATP 13.11 12.91 14.48 13.84 14.18 11.14 2.78
Tlr3
KLA  ATP  ATP+KLA
 NM_126166 toll-like receptor 3 (Tlr3), mRNA [NM_126166] KLA 8.54 10.04 12.64 11.83 10.51 7.08 3.09
ATP 1.09 1.16 1.16 1.16 .77 1.77 2.23
KLA/ATP 10.00 11.77 10.12 12.97 10.43 8.74 7.11
Tlr9
KLA  ATP  ATP+KLA
 NM_031178 toll-like receptor 9 (Tlr9), mRNA [NM_031178] KLA 1.08 1.09 1.18 1.15 1.34 1.25 1.16
ATP 1.04 1.05 1.23 1.85 1.41 1.06 1.21
KLA/ATP 1.16 1.17 1.45 1.88 1.67 1.32 1.46
Tnf
KLA  ATP  ATP+KLA
 NM_013693 tumor necrosis factor (Tnf), mRNA [NM_013693] KLA 13.35 12.76 10.71 9.03 10.64 7.39 8.32
ATP 2.01 2.48 8.27 19.20 9.72 4.09 1.49
KLA/ATP 12.72 15.76 12.73 17.34 5.10 3.61 6.07
Tnfrsf14
KLA  ATP  ATP+KLA
 BF580152 gb|602099161F1 NCI_CGAP_Co24 Mus musculus cDNA clone IMAGE:4219095 5. [BF580152] KLA 2.85 3.00 3.94 4.08 5.37 6.26 4.71
ATP .86 1.02 1.02 1.14 1.06 1.63 2.89
KLA/ATP 2.65 2.78 2.71 2.68 2.18 2.24 4.36
Tnfrsf14
KLA  ATP  ATP+KLA
 NM_178931 tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) (Tnfrsf14), mRNA [NM_178931] KLA 1.85 2.16 2.55 2.63 3.34 3.54 3.25
ATP .99 .95 1.15 1.16 .95 1.26 2.20
KLA/ATP 1.82 2.07 1.87 1.78 1.51 1.70 2.60
Tnfrsf1a
KLA  ATP  ATP+KLA
 NM_011609 tumor necrosis factor receptor superfamily, member 1a (Tnfrsf1a), mRNA [NM_011609] KLA 1.74 1.71 1.90 2.16 1.95 1.74 1.16
ATP .95 .83 .55 .41 .41 1.55 1.32
KLA/ATP 1.58 1.49 1.19 1.03 .98 2.02 2.10
Tnfsf14
KLA  ATP  ATP+KLA
 NM_019418 tumor necrosis factor (ligand) superfamily, member 14 (Tnfsf14), mRNA [NM_019418] KLA .57 .66 .55 .82 .48 .29 .22
ATP 1.16 1.25 1.61 8.55 24.98 15.54 3.28
KLA/ATP .88 .70 .86 3.41 17.39 10.12 1.56
Traf1
KLA  ATP  ATP+KLA
 NM_009421 Tnf receptor-associated factor 1 (Traf1), mRNA [NM_009421] KLA 44.86 39.03 38.11 34.21 36.49 19.69 14.75
ATP 1.14 1.04 1.98 8.16 16.79 30.81 6.36
KLA/ATP 46.20 45.67 45.63 38.00 27.26 31.47 63.83
Traf2
KLA  ATP  ATP+KLA
 NM_009422 Tnf receptor-associated factor 2 (Traf2), mRNA [NM_009422] KLA 3.38 3.62 3.49 3.36 3.49 3.39 2.68
ATP .97 1.04 1.00 1.10 1.54 2.40 1.55
KLA/ATP 3.38 3.16 2.93 2.74 2.67 3.11 4.70
Traf3
KLA  ATP  ATP+KLA
 NM_011632 Tnf receptor-associated factor 3 (Traf3), transcript variant 1, mRNA [NM_011632] KLA .52 .49 .51 .49 .80 .98 1.22
ATP .93 .92 .95 1.13 2.70 1.80 1.42
KLA/ATP .56 .50 .49 1.07 2.94 1.92 1.65
Traf5
KLA  ATP  ATP+KLA
 NM_011633 Tnf receptor-associated factor 5 (Traf5), mRNA [NM_011633] KLA 1.82 1.92 1.93 2.10 2.75 2.08 1.00
ATP 1.02 1.04 1.10 .78 3.79 2.22 1.42
KLA/ATP 1.70 1.89 1.85 1.64 5.40 2.10 1.83
Traf6
KLA  ATP  ATP+KLA
 NM_009424 Tnf receptor-associated factor 6 (Traf6), mRNA [NM_009424] KLA 1.19 1.28 1.34 1.20 1.23 1.23 1.28
ATP 1.06 1.12 .92 1.15 2.46 1.84 1.40
KLA/ATP 1.32 1.37 .89 1.16 1.45 1.49 1.46
Trp53
KLA  ATP  ATP+KLA
 NM_011640 transformation related protein 53 (Trp53), mRNA [NM_011640] KLA 1.25 1.37 1.11 .86 .72 .71 .95
ATP 1.15 1.32 .90 1.85 1.26 .68 .70
KLA/ATP 1.66 1.49 .80 1.76 .81 .65 .74
Tyk2
KLA  ATP  ATP+KLA
 NM_018793 tyrosine kinase 2 (Tyk2), mRNA [NM_018793] KLA 2.91 2.95 3.42 3.26 3.85 2.35 1.42
ATP 1.09 1.01 .68 .64 .59 .86 1.10
KLA/ATP 2.95 3.04 2.23 1.82 1.24 1.27 2.09
Ube2r2
KLA  ATP  ATP+KLA
 NM_026275 ubiquitin-conjugating enzyme E2R 2 (Ube2r2), mRNA [NM_026275] KLA 1.39 1.46 1.60 1.66 1.81 1.67 1.31
ATP 1.06 1.08 1.05 1.12 1.30 1.61 1.07
KLA/ATP 1.47 1.54 1.47 1.67 1.96 2.09 1.55
Usp7
KLA  ATP  ATP+KLA
 BC022588 ubiquitin specific peptidase 7, mRNA (cDNA clone IMAGE:4036999), **** WARNING: chimeric clone ****. [BC022588] KLA 1.29 1.16 1.15 1.01 1.20 1.07 1.01
ATP 1.22 1.35 1.25 1.13 1.42 1.03 .90
KLA/ATP 1.83 1.81 1.43 1.18 1.31 1.00 .89
Usp7
KLA  ATP  ATP+KLA
 NM_001003918 ubiquitin specific peptidase 7 (Usp7), mRNA [NM_001003918] KLA 1.49 1.46 1.42 1.41 1.07 .91 .91
ATP 1.01 .91 .90 .68 1.07 1.37 .87
KLA/ATP 1.45 1.50 1.44 .92 1.13 1.07 .73